The Indian generic drugs market is growing at good pace, owing to number of factors like increasing healthcare needs, expiry of patents of the branded drugs and government policies towards the same. Among the world’s largest generic drug suppliers, India exports over 20 percent of its generic drugs. By 2030, the Indian pharmaceutical industry will reach USD 130 billion and generic drugs will make a major contribution to this growth. Expanding opportunities for Indian manufacturers to produce cost effective alternatives is one of the key drivers, as several blockbuster drugs are due... >>More
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Sriram Ravilla, Managing Director, Aurolab
Andiappan Murugan, SVP - API R&D, Troikaa Pharmaceuticals
Saransh Chaudhary, President - Global Critical Care, Venus Remedies & CEO, Venus Medicine Research Centre
Sourabh Tiwari, CIO, Meril Group of Companies